Pacific Bio (PACB) Reports Q1 Loss of $0.20/Share

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.20), versus ($0.20) reported last year. Revenue for the quarter came in at $16.43 million, versus $19.36 million reported last year.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Deutsche Bank Starts DexCom (DXCM) at Buy